• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Bardet-Biedl syndrome 12 protein (BBS12)

ACP16165

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP16165 Target NameBBS12
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-710Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6ZW61
Background Information
  • Uniprot Id

    Q6ZW61

  • Target Species

    Human

  • Target Name

    BBS12

  • Target Full Name

    Chaperonin-containing T-complex member BBS12

  • Target Function

    Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis. As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Involved in adipogenic differentiation.

  • Target Involvement

    Bardet-Biedl syndrome 12 (BBS12)

  • Target Subcellular Location

    Cell projection, cilium.

  • Target Protein Families

    TCP-1 chaperonin family, BBS12 subfamily

  • Target Synonyms

    Bardet Biedl syndrome 12 protein; Bardet-Biedl syndrome 12 (human); Bardet-Biedl syndrome 12 protein; Bardet-Biedl syndrome 12 protein homolog; BBS12; BBS12 gene; BBS12_HUMAN; C4orf24; FLJ35630; FLJ41559; Gm1805; Gm407; Gm721; RP23-137F6.2

Inquire Recombinant Human Bardet-Biedl syndrome 12 protein (BBS12) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification